Table 3 Distribution of Bone Marker Values Compared to Premenopausal Reference Range Before and On Bisphosphonate Therapy (at least 3 months)
P1NP (μg/L) | CTX (ng/L) | |||
|---|---|---|---|---|
Baseline | Follow up | Baseline | Follow up | |
Below reference range (%) | 4 | 71 | 0 | 52 |
Lower half of reference range (%) | 14 | 26 | 65 | 45 |
Upper half of reference range (%) | 42 | 3 | 35 | 3 |
Above reference range (%) | 0 | 0 | 0 | 0 |